TickerKhojHospitals & Diagnostics · Hospital/Nursing Management · NSE: SHALBY · data 2026-11-01
Shalby Ltd.
In plain words
Price: 52.1% below its 52-week high of ₹252.05.
Delivery: 59.9% of traded shares were kept for delivery over the last 10 sessions, against 56.7% over the last 60.
Latest results: a net profit of ₹11 cr for the quarter ended Jun 2026 (+21.6% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,176 cr |
| Net profit (last 12 months) | ₹39 cr |
| Sales growth, 3 years (yearly) | 12.3% |
| Profit growth, 3 years (yearly) | -18.0% |
At a glance
Promoters 74.3% (unchanged in a year), pledged 0.0%, institutions 5.0%.
P/E 32.8, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 3.7%, ROCE 6.0%, operating margin 6.0%: how much profit it earns on the money it uses.
Debt/equity 0.59, Profit growth -18.0% and sales growth 12.3% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (3.7%).
- Profit fell 18.0% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
SHALBY Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹331.22 crore, up 11.7% YoY and up 15.2% QoQ.
Net profit was ₹10.85 crore, up 21.6% YoY and down 40.8% QoQ.
Operating margin was 12.6% (14% a year ago).
EPS was ₹0.98, up 38% YoY and down 43% QoQ.
SHALBY के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹331.22 करोड़; पिछले साल की तुलना में 11.7% की बढ़त, पिछली तिमाही की तुलना में 15.2% की बढ़त।
शुद्ध मुनाफ़ा: ₹10.85 करोड़; पिछले साल की तुलना में 21.6% की बढ़त, पिछली तिमाही की तुलना में 40.8% की गिरावट।
ऑपरेटिंग मार्जिन: 12.6% (एक साल पहले 14%)।
EPS: ₹0.98; पिछले साल की तुलना में 38% की बढ़त, पिछली तिमाही की तुलना में 43% की गिरावट।
SHALBYના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹331.22 કરોડ; ગયા વર્ષની સરખામણીએ 11.7% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 15.2% વધારો.
ચોખ્ખો નફો: ₹10.85 કરોડ; ગયા વર્ષની સરખામણીએ 21.6% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 40.8% ઘટાડો.
ઓપરેટિંગ માર્જિન: 12.6% (એક વર્ષ પહેલાં 14%).
EPS: ₹0.98; ગયા વર્ષની સરખામણીએ 38% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 43% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 57.2% over the last 20 sessions vs 57.2% in the 40 before (1x); shares delivered per day 0.8x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 12 Aug 26Results Q1 FY27 results: profit +21.6% YoY -3.4% next session
- 27 May 26Results Q4 FY26 results: turned to profit vs a year ago -2.9% next session
- 11 Feb 26Results Q3 FY26 results: turned to profit vs a year ago -5.1% next session
- 13 Nov 25Results Q2 FY26 results: profit +147.2% YoY -1.7% next session
- 13 Aug 25Results Q1 FY26 results: profit −39.5% YoY -1.4% next session
- 29 May 25Results Q4 FY25 results: turned to loss vs a year ago -6.0% next session
- 3 Feb 25Results Q3 FY25 results: turned to loss vs a year ago -5.4% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹331 cr | ₹11 cr | +21.6% | 12.6% | 0.98 |
| Mar 2026 | ₹287 cr | ₹18 cr | — | 10.2% | 1.72 |
| Dec 2025 | ₹272 cr | ₹2 cr | — | 11.1% | 0.12 |
| Sept 2025 | ₹285 cr | ₹8 cr | +147.2% | 14.6% | 0.68 |
Shareholding trend
| Holder | Sept 2026 | Mar 2026 | Dec 2025 | Sept 2025 |
|---|---|---|---|---|
| Promoters | 74.33% | 74.33% | 74.33% | 74.33% |
| Foreign institutions (FII) | 4.65% | 4.36% | 4.47% | 4.64% |
| Domestic institutions (DII) | 0.31% | 0.25% | 0.20% | 0.20% |
| Mutual funds | 0.02% | 0.00% | 0.00% | 0.00% |
| Retail investors | 9.66% | 9.40% | 9.41% | 9.32% |
| Number of shareholders | 50,572 | 51,415 | 52,495 | 53,784 |
Common questions
What was Shalby Ltd.'s latest quarterly profit?
Shalby Ltd. reported a net profit of ₹11 cr for the quarter ended Jun 2026 (+21.6% on the same quarter a year earlier), on revenue of ₹331 cr.
How much do promoters hold in Shalby Ltd.?
Promoters held 74.33% of Shalby Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Shalby Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.59.
What is Shalby Ltd.'s P/E ratio?
About 32.8, based on the last 12 months' earnings and a price of ₹120.64 (data 2026-11-01).
What is the 52-week high and low of Shalby Ltd.?
The 52-week high is ₹252.05 and the 52-week low is ₹110.61.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Shalby Ltd. | ₹120.64 | ₹1,306 cr | 32.8 | — | 3.7% | 6% | 0.59 | -51.3% |
| Indraprastha Medical Corporation Limited | ₹310 | ₹2,797 cr | 15.1 | — | 27.5% | 30% | 0.05 | -48.2% |
| KMC Speciality Hospitals (India) Limited | ₹149.93 | ₹2,422 cr | 43.8 | — | 24.9% | 25.1% | 0.4 | +8.9% |
| Gujarat Kidney & Super Speciality Ltd. | ₹165.47 | ₹1,289 cr | 82.4 | — | 11.1% | 14.7% | 0.12 | +37.9% |
| GPT Healthcare Limited | ₹133 | ₹1,089 cr | 23.1 | — | 16.3% | 16.2% | 0.34 | -11.5% |
| KRM Ayurveda Ltd. | ₹233.15 | ₹479 cr | — | — | — | — | — | +35.5% |
Compare SHALBY with INDRAMEDCO in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SHALBY in TickerKhoj →